Chainbase vs Symbiosis — how do they compare? Chainbase trades at Rp1,163 (market cap Rp422,03M, Rp77,81M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Chainbase is far larger — about 12.4× Symbiosis's market cap, and Chainbase's circulating supply is 362,6M / 1B C (37%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Chainbase for 9 Days and Symbiosis for 12 Days on average.
| C | SIS | |
|---|---|---|
Market Cap | Rp422,03M | Rp34,08M |
Volume (24h) | Rp77,81M | Rp2,71M |
Circulating Supply | 362,6M / 1B C (37%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 9 Days | 12 Days |
Signals from Pluang's Aura AI — not financial advice
Chainbase token is currently trading at Rp1,163.11 with a market cap of Rp416.72 million, showing bearish technical signals across multiple indicators. The asset faces selling pressure with 14 sell signals versus 4 buy signals, though oscillators remain neutral. With only 37% of the maximum 1 million token supply in circulation and an average hold time of 9 days, the token exhibits limited distribution and relatively short-term holding patterns.
Overall outlook remains cautious with technical weakness dominating. Key opportunities include potential accumulation at support levels, while major risks include low liquidity, bearish momentum, and limited network adoption. Investors should monitor for protocol developments and exchange liquidity improvements.
Symbiosis (SIS) is a cryptocurrency with a market cap of Rp34.08 million and a high circulation rate of 98%, indicating most tokens are in the market. The token has a max supply of 99.5 million SIS, with 97 million currently circulating. Hold time is relatively short at 12 days, suggesting active trading. No recent protocol updates or ecosystem developments were found.
Outlook: SIS presents a micro-cap opportunity with high liquidity due to near-full circulation, but faces significant risks from low market cap volatility and lack of recent developments. Key risks include price instability and limited exchange liquidity, while the opportunity lies in potential ecosystem growth if adoption increases.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Chainbase is developing the Hyperdata Network for AI, establishing a foundational layer for the DataFi era. This network converts fragmented on-chain signals into structured, verifiable, and AI-ready data, facilitating seamless collaboration among agents, applications, and humans. Chainbase empowers a decentralized data economy where data is treated as capital—composable, monetizable, and accessible to everyone.
Read more on C →Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →